Advertisement
Pharmaceutical Companies
Subscribe to Pharmaceutical Companies

The Lead

Pacific Biosciences Developing New Single Molecule Approach

April 27, 2015 11:15 am | by Globe Newswire | News | Comments

In a recent study by Richard Gibbs and colleagues from Baylor College of Medicine, this new enrichment method was used for de novo sequencing and detection of structural variation involved in human genetic disease.

Teva’s Potential $40 Billion Acquisition of Mylan Could Transform Generics Space

April 24, 2015 11:26 am | by GlobalData | News | Comments

Mylan made an unsolicited $28.9 billion offer to buy the Irish drugmaker last week, but Perrigo’...

AstraZeneca Profit Falls as Patent Expires on Heartburn Drug

April 24, 2015 10:43 am | by The Associated Press | News | Comments

Anglo-Swedish drug-maker AstraZeneca PLC reported a 7 percent fall in net profit for the first...

Divestment Gains Boost Net Earnings at Novartis

April 23, 2015 4:48 pm | by The Associated Press | News | Comments

Swiss-based pharmaceutical company Novartis reported a large jump in first-quarter net profit...

View Sample

FREE Email Newsletter

Mylan Launches Generic Sofosbuvir Tablets, MyHep, in India

April 23, 2015 10:30 am | by PRNewswire | News | Comments

The product is indicated for the treatment of chronic hepatitis C, a blood-borne infectious disease that affects more than 100 million people in the developing world, including approximately 12 million people in India.

Pfizer Says Leukemia Drug Met 1 Goal in Study

April 22, 2015 5:03 pm | by The Associated Press | News | Comments

Pfizer said that an experimental blood cancer drug met one of its two goals in a late-stage trial, as patients who were treated with the drug were more likely to have a complete remission.

Eli Lilly Biomanufacturing Plant For Sale

April 21, 2015 10:54 am | News | Comments

CBRE Group, Inc. announced today that they have been hired to sell Eli Lilly’s biomanufacturing plant in Vacaville, California.

Advertisement

Glaxo Recalls Flu Vaccine Due to Potency Problem

April 17, 2015 3:37 pm | by MATTHEW PERRONE, AP Health Writer | News | Comments

The company alerted U.S. customers Tuesday that the vaccine can lose potency and fail to adequately protect against some strains of the flu.

Merck CEO Frazier Becomes PhRMA Board Chairman

April 17, 2015 12:25 pm | News | Comments

Kenneth C. Frazier, chairman and CEO of Merck & Co., Inc., was elected chairman of the Board of the Pharmaceutical Research and Manufacturers of America (PhRMA).

FDA Approves First Generic To Treat MS

April 17, 2015 12:16 pm | by FDA | News | Comments

The U.S. Food and Drug Administration today approved the first generic version of Copaxone (glatiramer acetate injection), used to treat patients with relapsing forms of multiple sclerosis (MS).

Growth in Melanoma Treatment Driven by Bristol-Myers Squibb

April 16, 2015 11:35 am | News | Comments

The global treatment market for melanoma will expand more than fourfold in value from $1.34 billion in 2013 to reach an estimated $5.64 billion by 2023.

Innate Pharma and Sanofi Collaboration

April 16, 2015 11:28 am | by Innate Pharma SA | News | Comments

Innate Pharma SA has entered into a collaboration with Sanofi to apply site-specific conjugation technology to the development of new Antibody Drug Conjugate

Advertisement

Innocrin Raises $28 Million in Series D Financing

April 15, 2015 11:10 am | by Innocrin Pharmaceuticals | News | Comments

Innocrin Pharmaceuticals is developing small-molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers.

Ventana and Astellas Work on Targeted Cancer Treatments

April 14, 2015 11:09 am | by Ventana Medical Systems, Inc. | News | Comments

Ventana, a member of the Roche Group, announced it has entered into a master collaboration agreement with Astellas Pharma Inc.

Actavis: No Apologies for Seeking Alzheimer's Drug Profits

April 14, 2015 10:45 am | by Larry Neumeister, Associated Press | News | Comments

A lawyer for Actavis urged a U.S. appeals court on Monday to let it replace a two-pill daily regimen with a single-dose version of the drug even if it cheats generic drugmakers of profits.

Roche Acquires CAPP Medical

April 13, 2015 1:33 pm | by Roche | News | Comments

Roche has acquired CAPP Medical, a genomics research company founded by Stanford University oncologists and industry veterans.

Merck, Asian and African Universities Collaborate on Diabetes

April 13, 2015 12:49 pm | by Merck | News | Comments

Merck is introducing Clinical Diabetes management for more than 5000 medical students in 18 medical colleges of Maharashtra University as part of Merck Capacity Advancement Program (CAP) in Asia.

Advertisement

Merck's Puerto Rico Facility to be Sold

April 10, 2015 12:17 pm | by The Puerto Rico Industrial Development Company (PRIDCO) | News | Comments

Merck's agreement with AIAC is to sell the manufacturing facility in Arecibo that was under closing plans. AIAC will retain the approximately 200 Merck employees.

Baxter Recalls IV Solutions

April 10, 2015 11:42 am | by Baxter International | News | Comments

Baxter International Inc. announced today it is voluntarily recalling select lots of IV solutions to the hospital/user level due to the potential presence of particulate matter.

EU Approves Roche’s Avastin Therapy

April 9, 2015 12:06 pm | by Roche | News | Comments

The European Commission (EU) approved Avastin in combination with standard chemotherapy for the treatment of adult patients with carcinoma of the cervix.

Bristol-Myers Squibb Completes Acquisition of Flexus Biosciences

April 9, 2015 12:02 pm | by Bristol-Myers Squibb | News | Comments

Bristol-Myers Squibb has announced that it has completed its acquisition of Flexus Biosciences, Inc.

Pfizer Launches Competitive Grants Program

April 9, 2015 11:16 am | by Pfizer | News | Comments

Pfizer, Inc. is supporting research projects investigating the role of Proprotein Convertase Subtilisin Kexin type 9 (PCSK9) in health and cardiovascular disease.

Mylan Offers About $29B For Rival Generic Drugmaker Perrigo

April 8, 2015 2:28 pm | by MARLEY JAY, AP Business Writer | News | Comments

In a deal that would combine two generic drugmakers that recently left the U.S. for Europe, Mylan says it wants to buy Perrigo for $205 per share, or $28.86 billion.

Pfizer says Shoppers Drug Mart Acted Quickly on Expired Birth Control Pills

April 8, 2015 11:01 am | by The Canadian Press | News | Comments

The company that manufactures the birth control medication Alesse is giving Shoppers Drug Mart credit for alerting the public that expired pills had been dispensed in the last few weeks.

Study: Zoloft Increased Coronary Atherosclerosis

April 7, 2015 1:19 pm | by Wake Forest Baptist Medical Center | News | Comments

A commonly prescribed antidepressant caused up to a six-fold increase in atherosclerosis plaque in the coronary arteries of non-human primates.

Study: Mixed Picture on Viagra Effectiveness

April 7, 2015 1:15 pm | by University of Manchester | News | Comments

Viagra and other related drugs are not a universal 'cure-all' for impotence, according to a new study from The University of Manchester.

Shares of Arena Rise Due to Weight Loss Drug Patent

April 7, 2015 12:42 pm | by The Associated Press | News | Comments

Shares of Arena Pharmaceuticals rose Tuesday after the drug developer said it received an additional patent for its weight loss drug Belviq.

Arvinas Strategic R&D Collaboration with Merck

April 7, 2015 12:36 pm | by Arvinas | News | Comments

Arvinas announced a strategic collaboration with Merck with the goal of creating novel therapeutics based on protein degradation.

New Patent for Low-Sodium Bendamustine

April 7, 2015 12:29 pm | by Eagle Pharmaceuticals | News | Comments

Eagle Pharmaceuticals, Inc. today announced a patent for the use of bendamustine for treating patients requiring restricted fluid and/or sodium intake. 

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading